Effects of a honeybee sting on the serum free amino acid profile in humans

Jan Matysiak, Paweł Dereziński, Agnieszka Klupczyńska, Joanna Matysiak, Elżbieta Kaczmarek, Zenon J Kokot, Jan Matysiak, Paweł Dereziński, Agnieszka Klupczyńska, Joanna Matysiak, Elżbieta Kaczmarek, Zenon J Kokot

Abstract

The aim of this study was to assess the response to a honeybee venom by analyzing serum levels of 34 free amino acids. Another goal of this study was to apply complex analytic-bioinformatic-clinical strategy based on up-to-date achievements of mass spectrometry in metabolomic profiling. The amino acid profiles were determined using hybrid triple quadrupole/linear ion trap mass spectrometer coupled with a liquid chromatography instrument. Serum samples were collected from 27 beekeepers within 3 hours after they were stung and after a minimum of 6 weeks following the last sting. The differences in amino acid profiles were evaluated using MetaboAnalyst and ROCCET web portals. Chemometric tests showed statistically significant differences in the levels of L-glutamine (Gln), L-glutamic acid (Glu), L-methionine (Met) and 3-methyl-L-histidine (3MHis) between the two analyzed groups of serum samples. Gln and Glu appeared to be the most important metabolites for distinguishing the beekeepers tested shortly after a bee sting from those tested at least 6 weeks later. The role of some amino acids in the response of an organism to the honeybee sting was also discussed. This study indicated that proposed methodology may allow to identify the individuals just after the sting and those who were stung at least 6 weeks earlier. The results we obtained will contribute to better understanding of the human body response to the honeybee sting.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Extracted ion chromatograms of isobaric…
Figure 1. Extracted ion chromatograms of isobaric amino acids acquired during the analysis of one of the serum sample.
a: identified amino acids: 1-1MHis; 2-3MHis; b: identified amino acids: 1-Val; 2–Nval; c: identified amino acids: 1-Sar; 2-bAla; 3–Ala.
Figure 2. Three-dimensional (3D) partial least squares…
Figure 2. Three-dimensional (3D) partial least squares discriminant analysis separation using amino acids concentration-based metabolomics measurements in the serum of the beekeepers directly after a bee sting vs. the serum of the beekeepers after at least six weeks since the last sting (27 cases).
The explained variances are shown in brackets.
Figure 3. Variable importance in projection (VIP)…
Figure 3. Variable importance in projection (VIP) plot: important features (analyzed serum free amino acids) identified by PLS-DA in a descending order of importance.
The graph represents relative contribution of amino acids to the variance between the stung and non-stung individuals. High value of VIP score indicates great contribution of the amino acids to the group separation. The black and white boxes on the right indicate whether the metabolite concentration is increased (black) or decreased (white) in the serum of the stung vs. non-stung beekeepers.
Figure 4. Significant features identified by SAM…
Figure 4. Significant features identified by SAM (Significance Analysis of Microarray (Delta = 0.3).
The more the variable deviates from the “observed-expected d” line, the more likely it is to be significant. The bold dots represent features that exceed the specified threshold (cutlow = –1.134, cutup = 1.155). Significant positive compounds (i.e. mean concentration in the serum of the beekeepers directly after a bee sting > mean concentration in the serum of the beekeepers after at least six weeks since the last sting): Glu (d.value = 2.717), 3MHis (d.value = 1.155). Significant negative compounds (i.e. mean concentration in the serum of the beekeepers directly after a bee sting

Figure 5

A: Receiver operating characteristic (ROC)…

Figure 5

A: Receiver operating characteristic (ROC) curve for Gln. Cut-off value: 396.0 µM/l. Specificity:…
Figure 5
A: Receiver operating characteristic (ROC) curve for Gln. Cut-off value: 396.0 µM/l. Specificity: 90%, sensitivity: 90%. Area under the curve (AUC): 0.912, confidence interval: 95% (0.816–0.979); B: Concentration of Gln in two groups of beekeepers (directly after a sting and at least six weeks since the last sting). Dotted line indicates a cut-off value of 396.0 µM/l.
Figure 5
Figure 5
A: Receiver operating characteristic (ROC) curve for Gln. Cut-off value: 396.0 µM/l. Specificity: 90%, sensitivity: 90%. Area under the curve (AUC): 0.912, confidence interval: 95% (0.816–0.979); B: Concentration of Gln in two groups of beekeepers (directly after a sting and at least six weeks since the last sting). Dotted line indicates a cut-off value of 396.0 µM/l.

References

    1. Bilo BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JN (2005) Diagnosis of Hymenoptera venom allergy. Allergy 60: 1339–1349.
    1. Matysiak J, Matysiak J, Breborowicz A, Kokot ZJ (2013) Diagnosis of hymenoptera venom allergy - with special emphasis on honeybee (Apis mellifera) venom allergy. Ann Agric Environ Med 20: 875–879.
    1. Varga EM, Kausar F, Aberer W, Zach M, Eber E, et al. (2013) Tolerant beekeepers display venom-specific functional IgG4 antibodies in the absence of specific IgE. J Allergy Clin Immunol 131: 1419–1421.
    1. Dang NA, Kuijper S, Walters E, Claassens M, van Soolingen D, et al. (2013) Validation of biomarkers for distinguishing Mycobacterium tuberculosis from non-tuberculous mycobacteria using gas chromatography-mass spectrometry and chemometrics. PLoS One 8: e76263.
    1. Austdal M, Skrastad RB, Gundersen AS, Austgulen R, Iversen AC, et al. (2014) Metabolomic biomarkers in serum and urine in women with preeclampsia. PLoS One 9: e91923.
    1. Chung SY, Reed S (2013) Effect of D-Amino Acids On IgE Binding to Peanut Allergens. Journal of Allergy and Clinical Immunology 131: Ab20–Ab20.
    1. Saude EJ, Skappak CD, Regush S, Cook K, Ben-Zvi A, et al. (2011) Metabolomic profiling of asthma: Diagnostic utility of urine nuclear magnetic resonance spectroscopy. Journal of Allergy and Clinical Immunology 127: 757–U408.
    1. Massey KA, Blakeslee CH, Pitkow HS (1998) A review of physiological and metabolic effects of essential amino acids. Amino Acids 14: 271–300.
    1. Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, et al. (2011) Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS One 6: e24143.
    1. Dejong CH, van de Poll MC, Soeters PB, Jalan R, Olde Damink SW (2007) Aromatic amino acid metabolism during liver failure. J Nutr 137: 1579S–1585S discussion 1597S–1598S.
    1. Campollo O, Sprengers D, McIntyre N (1992) The BCAA/AAA ratio of plasma amino acids in three different groups of cirrhotics. Rev Invest Clin 44: 513–518.
    1. Cano NJ, Fouque D, Leverve XM (2006) Application of branched-chain amino acids in human pathological states: renal failure. J Nutr 136: 299S–307S.
    1. Lai HS, Lee JC, Lee PH, Wang ST, Chen WJ (2005) Plasma free amino acid profile in cancer patients. Seminars in Cancer Biology 15: 267–276.
    1. Maeda J, Higashiyama M, Imaizumi A, Nakayama T, Yamamoto H, et al. (2010) Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study. BMC Cancer 10: 690.
    1. Cascino A, Muscaritoli M, Cangiano C, Conversano L, Laviano A, et al. (1995) Plasma amino acid imbalance in patients with lung and breast cancer. Anticancer Res 15: 507–510.
    1. Leichtle AB, Nuoffer JM, Ceglarek U, Kase J, Conrad T, et al. (2012) Serum amino acid profiles and their alterations in colorectal cancer. Metabolomics 8: 643–653.
    1. Stabler S, Koyama T, Zhao Z, Martinez-Ferrer M, Allen RH, et al. (2011) Serum methionine metabolites are risk factors for metastatic prostate cancer progression. PLoS One 6: e22486.
    1. Walford GA, Davis J, Warner AS, Ackerman RJ, Billings LK, et al... (2013) Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus. Metabolism.
    1. Deng K, Lin S, Zhou L, Geng Q, Li Y, et al. (2011) Three aromatic amino acids in gastric juice as potential biomarkers for gastric malignancies. Anal Chim Acta 694: 100–107.
    1. Mayboroda OA, Neususs C, Pelzing M, Zurek G, Derks R, et al. (2007) Amino acid profiling in urine by capillary zone electrophoresis - mass spectrometry. J Chromatogr A 1159: 149–153.
    1. Zhang JB, Li MJ, Li Z, Yan XJ, Yuan JQ, et al. (2013) Study on urinary profile of inborn errors of metabolism by 18-crown-6 modified capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 929: 102–106.
    1. Bartolomeo MP, Maisano F (2006) Validation of a reversed-phase HPLC method for quantitative amino acid analysis. J Biomol Tech 17: 131–137.
    1. Ponder EL, Fried B, Sherma J (2003) Effects of hypotonicity on amino acid release in adult Echinostoma caproni as determined by thin layer chromatography. Parasitol Res 89: 242–244.
    1. Le Boucher J, Charret C, Coudray-Lucas C, Giboudeau J, Cynober L (1997) Amino acid determination in biological fluids by automated ion-exchange chromatography: performance of Hitachi L-8500A. Clin Chem 43: 1421–1428.
    1. Held PK, White L, Pasquali M (2011) Quantitative urine amino acid analysis using liquid chromatography tandem mass spectrometry and aTRAQ reagents. J Chromatogr B Analyt Technol Biomed Life Sci 879: 2695–2703.
    1. Xia J, Mandal R, Sinelnikov IV, Broadhurst D, Wishart DS (2012) MetaboAnalyst 2.0–a comprehensive server for metabolomic data analysis. Nucleic Acids Res 40: W127–133.
    1. Xia J, Broadhurst DI, Wilson M, Wishart DS (2013) Translational biomarker discovery in clinical metabolomics: an introductory tutorial. Metabolomics 9: 280–299.
    1. Xia J, Psychogios N, Young N, Wishart DS (2009) MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res 37: W652–660.
    1. Nedergaard M, Takano T, Hansen AJ (2002) Beyond the role of glutamate as a neurotransmitter. Nat Rev Neurosci 3: 748–755.
    1. Weinberg RJ (1999) Glutamate: an excitatory neurotransmitter in the mammalian CNS. Brain Res Bull 50: 353–354.
    1. D’Andrea G, Cananzi AR, Joseph R, Morra M, Zamberlan F, et al. (1991) Platelet glycine, glutamate and aspartate in primary headache. Cephalalgia 11: 197–200.
    1. Gallai V, Alberti A, Gallai B, Coppola F, Floridi A, et al. (2003) Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid. Cephalalgia 23: 166–174.
    1. Lee WJ, Hawkins RA, Vina JR, Peterson DR (1998) Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal. Am J Physiol 274: C1101–1107.

Source: PubMed

3
Se inscrever